Stock listing

NASDAQ:FBIO Fortress Biotech, Inc. Stock

Home listing (NASDAQ) of Fortress Biotech, Inc.

Follow Fortress Biotech, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:FBIO

$1.92 USD -0.08 (-4.0%)

Close on Oct 30, 2026

Past year -25.3% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$1.89 – $2.01 USDOct 30, 2026
Volume
193,398 sharesOct 30, 2026
Market cap
$64.03M USDAt the close on Oct 30, 2026 · price × 33.35M shares outstanding
52-week range
$1.83 – $4.53 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$1.06M USDMedian day 281,800 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Fortress Biotech, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:FBIO · Home$1.92 USD-0.08 (-4.0%)193,398$2.01$2.01$1.89$2.00Close on Oct 30, 2026
NASDAQ:FBIOP$16.01 USD-0.44 (-2.7%)23,560$16.06$16.18$15.78$16.45Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:FBIO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.92-0.08-4.0%$2.01$2.01$1.89193,398
$2.00+0.04+2.0%$2.00$2.069$1.97179,305
$1.96+0.03+1.6%$1.94$1.98$1.91125,196
$1.93+0.06+3.2%$1.90$1.95$1.87157,132
$1.87-0.06-3.1%$1.91$1.92$1.85114,323
$1.93-0.06-3.0%$1.98$1.99$1.91223,300
$1.99+0.05+2.6%$1.94$2.01$1.93183,300
$1.940.000.0%$1.94$1.96$1.92178,200
$1.94+0.07+3.7%$1.88$1.95$1.88293,900
$1.870.000.0%$1.88$1.89$1.83251,000
$1.87-0.04-2.1%$1.92$1.93$1.84264,300
$1.91+0.01+0.5%$1.91$1.95$1.88219,400
$1.90-0.05-2.6%$1.93$1.95$1.88376,100
$1.95-0.16-7.6%$2.09$2.11$1.93443,500
$2.11-0.03-1.4%$2.12$2.13$2.10113,300
$2.14+0.05+2.4%$2.12$2.17$2.09186,200
$2.09+0.05+2.5%$2.03$2.10$2.02265,300
$2.04-0.01-0.5%$2.02$2.06$2.00146,100
$2.05-0.04-1.9%$2.09$2.13$2.02220,000
$2.09+0.06+3.0%$2.03$2.14$2.00553,400
$2.03-0.04-1.9%$2.08$2.09$2.01326,700
$2.07-0.07-3.3%$2.17$2.17$2.07276,900
$2.14-0.06-2.7%$2.20$2.20$2.14221,200
$2.20+0.03+1.4%$2.20$2.21$2.14257,200
$2.17-0.11-4.8%$2.26$2.27$2.17262,800
$2.280.000.0%$2.27$2.32$2.26264,900
$2.28-0.06-2.6%$2.33$2.35$2.28203,600
$2.34-0.11-4.5%$2.45$2.45$2.33331,800
$2.45+0.04+1.7%$2.42$2.47$2.40199,700
$2.41-0.10-4.0%$2.50$2.52$2.39283,200
$2.510.000.0%$2.50$2.57$2.47414,700
$2.51+0.05+2.0%$2.49$2.51$2.44167,500
$2.46-0.03-1.2%$2.48$2.51$2.41352,900
$2.49-0.04-1.6%$2.51$2.53$2.46225,300
$2.53+0.01+0.4%$2.50$2.54$2.46226,500
$2.52-0.05-1.9%$2.59$2.625$2.52209,700
$2.57-0.06-2.3%$2.60$2.63$2.53315,400
$2.63-0.08-3.0%$2.67$2.70$2.62280,400
$2.71-0.01-0.4%$2.69$2.75$2.67263,000
$2.72+0.01+0.4%$2.68$2.74$2.68168,100
$2.71-0.02-0.7%$2.75$2.76$2.70147,900
$2.73+0.05+1.9%$2.67$2.74$2.67279,800
$2.68-0.06-2.2%$2.69$2.77$2.63605,800
$2.74-0.03-1.1%$2.80$2.80$2.69326,300
$2.77-0.03-1.1%$2.80$2.81$2.75309,600
$2.80-0.01-0.4%$2.84$2.88$2.77460,300
$2.81-0.02-0.7%$2.79$2.88$2.78395,800
$2.83-0.10-3.4%$2.95$2.99$2.78451,300
$2.93+0.06+2.1%$2.83$2.99$2.83603,900
$2.87+0.10+3.6%$2.80$2.88$2.79202,700
$2.77-0.08-2.8%$2.80$2.87$2.75323,800
$2.85-0.06-2.1%$2.93$2.93$2.79536,600
$2.91+0.09+3.2%$2.82$2.91$2.76593,200
$2.82-0.11-3.8%$2.89$2.90$2.73838,800
$2.93-0.05-1.7%$2.92$3.02$2.711,031,500
$2.98+0.23+8.4%$2.76$3.06$2.701,394,100
$2.75+0.14+5.4%$2.61$2.78$2.571,007,800
$2.61-0.14-5.1%$2.74$2.74$2.60617,200
$2.75+0.08+3.0%$2.66$2.79$2.63542,700
$2.67-0.10-3.6%$2.77$2.85$2.65579,800
$2.77-0.02-0.7%$2.79$2.85$2.70651,400
$2.79+0.07+2.6%$2.78$2.88$2.75702,300
$2.72-0.04-1.4%$2.70$2.80$2.66992,400
$2.76-0.37-11.8%$2.97$2.97$2.622,314,400
$3.13-0.16-4.9%$3.28$3.28$3.08642,800
$3.29-0.06-1.8%$3.36$3.45$3.27463,700
Ticker
NASDAQ:FBIO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Fortress Biotech (NASDAQ:FBIO) Q3 2025 Earnings Call

    Wed, Nov 12, 2025 · 4:30 PM ET

    Watch Transcript

  • Fortress Biotech (NASDAQ:FBIO) Q4 2024 Earnings Call

    Wed, Mar 26, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Sep 8, 2026

Closed $2.71 (-0.4%) on Sep 8, 2026

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Aug 13, 2026

Closed $2.93 (-1.7%) on Aug 14, 2026

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics $130 Million Series B Financing

Jul 28, 2026

Closed $3.39 (+3.7%) on Jul 28, 2026

Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference

May 18, 2026

Closed $2.48 (+2.9%) on May 18, 2026

Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

May 14, 2026

Closed $2.41 (+4.8%) on May 15, 2026

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

May 4, 2026

Closed $2.38 (+2.1%) on May 4, 2026

Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™

Apr 21, 2026

Closed $2.23 (-3.9%) on Apr 21, 2026

Issued by another party

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

Mar 31, 2026

Closed $2.79 (+3.3%) on Mar 31, 2026

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

Mar 30, 2026

Closed $2.70 (-2.2%) on Mar 30, 2026

Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

Mar 18, 2026

Closed $3.16 (+1.3%) on Mar 18, 2026

Issued by another party

All Fortress Biotech, Inc. news

Decks

Fortress Biotech, Inc. on 6ix

News releases
21 in the last 12 months · 130 in all · newest Sep 8, 2026 · oldest 2019
Calls
2 calls with a replay · 2 with a transcript · latest Nov 12, 2025
Decks
24 decks · latest September 2026

Where Fortress Biotech, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:FBIO · Home listing · This pageNASDAQUnited StatesUSD
NASDAQ:FBIOPNASDAQUnited StatesUSD
BOATS:FBIOPBOATSUnited StatesUSD
BOATS:FBIOBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Fortress Biotech, Inc.